A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients

NCT04161430 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

766

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: DBPR108; Placebo matching sitagliptin
DRUG: Placebo matching DBPR108; Sitagliptin; DBPR108
DRUG: Placebo matching DBPR108; Placebo matching sitagliptin; DBPR108

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.